Positive phase II results for arginine deiminase in HCC support initiation of phase III trial July 28, 2003
Lead NPI-2350 (halimide) analogues with improved cytotoxic activity presented at AACR meeting July 28, 2003
Antitumor and antiinflammatory properties of synthetic triterpenoids under study at Dartmouth July 28, 2003
E-7389 analogues designed to have minimal susceptibility to P-glycoprotein-mediated drug efflux July 28, 2003
Humanized antibodies targeting denatured collagen inhibit angiogenesis and tumor growth July 25, 2003
RSS